Most Popular

Quant Ratings Updated on 135 Blue Chips—See What Changed Quant Ratings Updated on 135 Blue-Chip Stocks—Find Out What Changed

I’ve revised my Stock Grader recommendations. Here’s which stocks moved up and which ones moved down. Last week, President Trump shocked everyone by implementing 25% tariffs on two of the U.S.’s biggest trading partners: Canada and Mexico. But these threats were short-lived. As discussed in a …

Read more

Wall Street Analysts See Interactive Brokers (IBKR) as a Buy: Should You Invest?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock’s price. Do they really matter, though? Let’s take …

Read more

Top 2 Materials Stocks That Could Blast Off This Quarter – Tronox Holdings (NYSE:TROX), Brazil Potash (AMEX:GRO)

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to …

Read more

UnitedHealth Group Stock: Is UNH Underperforming the Healthcare Sector?

Minnetonka, Minnesota-based UnitedHealth Group Incorporated (UNH) operates as a diversified healthcare company. With a market cap of $426.6 billion, UnitedHealth provides a range of healthcare products and services and operates through UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx segments. Companies worth $10 billion or …

Read more

NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm – Neumora Therapeutics (NASDAQ:NMRA)

LOS ANGELES, Feb. 25, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Neumora Therapeutics, Inc. (“Neumora” or “the Company”) NMRA for violations of the federal securities laws. Investors who purchased the Company’s …

Read more

Is the Party Over for Nvidia on Feb. 26? One Figure Provides a Clear Answer.

For more than two years, the bulls have ruled the roost on Wall Street. The mature stock-powered Dow Jones Industrial Average, benchmark S&P 500, and innovation-inspired Nasdaq Composite have all vaulted to numerous record-closing highs. Although upside catalysts have been abundant and include the likes …

Read more

Daily Dividend Report: NVDA,ALL,RY,TD,VTRS | Nasdaq

NVIDIA will pay its next quarterly cash dividend of $0.01 per share on April 2, 2025, to all shareholders of record on March 12, 2025. Allstate announced that its board of directors approved a quarterly common stock dividend of $1.00 on Feb. 26, 2025, which …

Read more

Is ORCL Stock a Buy, Sell or Hold at an EV/EBITDA Multiple of 21.89X?

Oracle’s ORCL stretched valuation metrics promote compelling reasons why investors should consider selling the stock in 2025. Oracle currently trades at an elevated EV/EBITDA multiple of 21.89x, significantly higher than the Zacks Computer-Software industry average of 16.41x. This premium valuation suggests that investors have already …

Read more

Nvidia Earnings: Here’s Why the Stellar Q4 Results Got a Cold Market Reception

Nvidia (NASDAQ:) crushed expectations on Wednesday, yet its stock wobbled for a brief period in after-hours trading, before recovering in pre-market action. The mixed reaction signals uncertainty as investors brace for today’s session. At first glance, the AI chip giant delivered a stellar performance. Q4 …

Read more

Market Shift: These 3 Stocks Are Winning While Big Tech Lags – Dutch Bros (NYSE:BROS), Doximity (NYSE:DOCS)

As earnings season winds down, a notable trend has emerged in the markets: several mega-cap stocks have underperformed year-to-date (YTD). In contrast, several mid-to-large cap stocks with strong retail followings have delivered superior returns. This shift in market dynamics is significant, given the influence of …

Read more